Clinical Trials
7 trialsNCT06084845 2024-07-25
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Eastern Cooperative Oncology Group
Phase 2 Withdrawn
NCT04892875 2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1 Withdrawn
NCT00499291 2023-05-25
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT05512767 2023-01-06
A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation
Mayo Clinic
Phase NA Withdrawn
NCT02251639 2017-04-27
Diagnostic Aids for Detection and Diagnosis of Oral Cancer
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT00006106 2013-07-10
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT00951470 2012-09-07
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
M.D. Anderson Cancer Center
Phase NA Withdrawn